ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 189 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,725,000 | +68.5% | 101,500 | +1.5% | 0.33% | +30.7% |
| Q4 2018 | $1,617,000 | +7.4% | 100,000 | +37.9% | 0.25% | +78.9% |
| Q3 2018 | $1,505,000 | +97.0% | 72,500 | +45.0% | 0.14% | +89.3% |
| Q2 2018 | $764,000 | -32.0% | 50,000 | 0.0% | 0.08% | -35.3% |
| Q1 2018 | $1,124,000 | -25.4% | 50,000 | 0.0% | 0.12% | -40.5% |
| Q4 2017 | $1,506,000 | -20.1% | 50,000 | 0.0% | 0.20% | -21.4% |
| Q3 2017 | $1,884,000 | +32.5% | 50,000 | -2.0% | 0.25% | +32.6% |
| Q2 2017 | $1,422,000 | -17.3% | 51,000 | +2.0% | 0.19% | -16.5% |
| Q1 2017 | $1,719,000 | +19.2% | 50,000 | 0.0% | 0.22% | +23.1% |
| Q4 2016 | $1,442,000 | -9.4% | 50,000 | 0.0% | 0.18% | -14.2% |
| Q3 2016 | $1,591,000 | -2.0% | 50,000 | 0.0% | 0.21% | +2.9% |
| Q2 2016 | $1,623,000 | +9.5% | 50,000 | -5.7% | 0.21% | +13.2% |
| Q1 2016 | $1,482,000 | -21.5% | 53,000 | 0.0% | 0.18% | -15.0% |
| Q4 2015 | $1,889,000 | – | 53,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |